Alphatec Holdings (ATEC) Non-Current Debt (2010 - 2026)
Alphatec Holdings' (ATEC) quarterly Non-Current Debt came in at $507.9 million in Q1 2026, down 6.95% year-on-year from $545.8 million in Q1 2025, and up 1.29% quarter-over-quarter from $501.4 million in Q4 2025.
Alphatec Holdings (ATEC) Non-Current Debt (2010 - 2026) Analysis & Trends
Alphatec Holdings has disclosed Non-Current Debt across 17 years of filings, most recently posting $507.9 million for Q1 2026.
- Non-Current Debt for Q1 2026 came in at $507.9 million, down 6.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $507.9 million (down 6.95% YoY), and the FY2025 annual result was $501.4 million, down 12.73% from the prior year.
- Non-Current Debt came in at $507.9 million for Q1 2026 at Alphatec Holdings, up from $501.4 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $574.5 million in Q4 2024 to a low of $313.4 million in Q2 2022.
- The 5-year median for Non-Current Debt is $506.6 million (2023), against an average of $468.3 million.
- Across the five-year window, Non-Current Debt jumped 746.65% in 2022 and declined 12.73% in 2025, its largest moves.
- Alphatec Holdings' Non-Current Debt stood at $349.5 million in 2022, then surged by 46.21% to $511.0 million in 2023, then advanced by 12.42% to $574.5 million in 2024, then slipped by 12.73% to $501.4 million in 2025, then advanced by 1.29% to $507.9 million in 2026.
- The last three Non-Current Debt figures came in at $507.9 million (Q1 2026), $501.4 million (Q4 2025), and $495.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 27.88 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.81 Bn |
| 10 | Alphatec Holdings | 1.34 Bn | 1.20 Bn | 136.48 Mn | 507.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 507.89 Mn |
| Mar 31, 2026 | 507.89 Mn |
| Dec 31, 2025 | 501.41 Mn |
| Dec 31, 2025 | 501.41 Mn |
| Sep 30, 2025 | 495.02 Mn |
| Sep 30, 2025 | 495.02 Mn |
| Jun 30, 2025 | 551.99 Mn |
| Jun 30, 2025 | 551.99 Mn |
| Mar 31, 2025 | 545.83 Mn |
| Mar 31, 2025 | 545.83 Mn |
| Dec 31, 2024 | 574.52 Mn |
| Dec 31, 2024 | 574.52 Mn |
| Sep 30, 2024 | 525.94 Mn |
| Sep 30, 2024 | 525.94 Mn |
| Jun 30, 2024 | 516.88 Mn |
| Jun 30, 2024 | 516.88 Mn |
| Mar 31, 2024 | 511.89 Mn |
| Mar 31, 2024 | 511.89 Mn |
| Dec 31, 2023 | 511.04 Mn |
| Dec 31, 2023 | 511.04 Mn |